GO:0046961 | proton-transporting ATPase activity, rotational mechanism | 3.62e-05 | 5.22e-01 | 7.739 | 2 | 3 | 15 |
GO:0070062 | extracellular vesicular exosome | 9.23e-05 | 1.00e+00 | 2.225 | 7 | 104 | 2400 |
GO:0015991 | ATP hydrolysis coupled proton transport | 1.12e-04 | 1.00e+00 | 6.946 | 2 | 4 | 26 |
GO:0015992 | proton transport | 1.39e-04 | 1.00e+00 | 6.788 | 2 | 3 | 29 |
GO:0031625 | ubiquitin protein ligase binding | 1.47e-04 | 1.00e+00 | 4.755 | 3 | 14 | 178 |
GO:0033572 | transferrin transport | 1.49e-04 | 1.00e+00 | 6.739 | 2 | 5 | 30 |
GO:0051701 | interaction with host | 1.70e-04 | 1.00e+00 | 6.646 | 2 | 4 | 32 |
GO:0016032 | viral process | 2.02e-04 | 1.00e+00 | 3.585 | 4 | 55 | 534 |
GO:0090382 | phagosome maturation | 2.16e-04 | 1.00e+00 | 6.476 | 2 | 5 | 36 |
GO:0006879 | cellular iron ion homeostasis | 4.34e-04 | 1.00e+00 | 5.974 | 2 | 4 | 51 |
GO:0005019 | platelet-derived growth factor beta-receptor activity | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0005017 | platelet-derived growth factor-activated receptor activity | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0060981 | cell migration involved in coronary angiogenesis | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0035789 | metanephric mesenchymal cell migration | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0004713 | protein tyrosine kinase activity | 1.12e-03 | 1.00e+00 | 5.289 | 2 | 5 | 82 |
GO:0005925 | focal adhesion | 1.21e-03 | 1.00e+00 | 3.715 | 3 | 19 | 366 |
GO:0071670 | smooth muscle cell chemotaxis | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0004992 | platelet activating factor receptor activity | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 2 | 2 |
GO:0035441 | cell migration involved in vasculogenesis | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0005055 | laminin receptor activity | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0005829 | cytosol | 1.39e-03 | 1.00e+00 | 1.946 | 6 | 132 | 2496 |
GO:0016020 | membrane | 1.80e-03 | 1.00e+00 | 2.253 | 5 | 90 | 1681 |
GO:0072278 | metanephric comma-shaped body morphogenesis | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0038091 | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0072277 | metanephric glomerular capillary formation | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0038085 | vascular endothelial growth factor binding | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 |
GO:0019788 | NEDD8 ligase activity | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 2.87e-03 | 1.00e+00 | 4.602 | 2 | 7 | 132 |
GO:0005654 | nucleoplasm | 2.92e-03 | 1.00e+00 | 2.567 | 4 | 76 | 1082 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 3 | 5 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0043248 | proteasome assembly | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0030891 | VCB complex | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 2 | 5 |
GO:0033179 | proton-transporting V-type ATPase, V0 domain | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0005131 | growth hormone receptor binding | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0036120 | cellular response to platelet-derived growth factor stimulus | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0000730 | DNA recombinase assembly | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:2000001 | regulation of DNA damage checkpoint | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0072284 | metanephric S-shaped body morphogenesis | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0008286 | insulin receptor signaling pathway | 3.31e-03 | 1.00e+00 | 4.496 | 2 | 7 | 142 |
GO:0000082 | G1/S transition of mitotic cell cycle | 3.64e-03 | 1.00e+00 | 4.427 | 2 | 32 | 149 |
GO:0030957 | Tat protein binding | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 3 | 6 |
GO:0031466 | Cul5-RING ubiquitin ligase complex | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 6 |
GO:0033180 | proton-transporting V-type ATPase, V1 domain | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 2 | 7 |
GO:0000028 | ribosomal small subunit assembly | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 7 |
GO:0061298 | retina vasculature development in camera-type eye | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 7 |
GO:0031462 | Cul2-RING ubiquitin ligase complex | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 2 | 7 |
GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 2 | 8 |
GO:0072075 | metanephric mesenchyme development | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0010863 | positive regulation of phospholipase C activity | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0034405 | response to fluid shear stress | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0045116 | protein neddylation | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 2 | 8 |
GO:0005515 | protein binding | 5.23e-03 | 1.00e+00 | 1.090 | 8 | 184 | 6024 |
GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 1 | 9 |
GO:0031702 | type 1 angiotensin receptor binding | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 1 | 9 |
GO:0005524 | ATP binding | 5.68e-03 | 1.00e+00 | 2.304 | 4 | 60 | 1298 |
GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 10 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 10 |
GO:0046488 | phosphatidylinositol metabolic process | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 10 |
GO:0005765 | lysosomal membrane | 6.65e-03 | 1.00e+00 | 3.981 | 2 | 5 | 203 |
GO:0048407 | platelet-derived growth factor binding | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 11 |
GO:0055003 | cardiac myofibril assembly | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 11 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 4 | 11 |
GO:0048745 | smooth muscle tissue development | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 11 |
GO:2000573 | positive regulation of DNA biosynthetic process | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 11 |
GO:0035909 | aorta morphogenesis | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 12 |
GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 12 |
GO:0005838 | proteasome regulatory particle | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 7 | 12 |
GO:0016071 | mRNA metabolic process | 7.98e-03 | 1.00e+00 | 3.845 | 2 | 31 | 223 |
GO:0050921 | positive regulation of chemotaxis | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 2 | 13 |
GO:0005662 | DNA replication factor A complex | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 13 |
GO:0055093 | response to hyperoxia | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 13 |
GO:0031226 | intrinsic component of plasma membrane | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 13 |
GO:0090280 | positive regulation of calcium ion import | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 4 | 14 |
GO:0005161 | platelet-derived growth factor receptor binding | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 1 | 14 |
GO:0046034 | ATP metabolic process | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 1 | 15 |
GO:0016070 | RNA metabolic process | 9.71e-03 | 1.00e+00 | 3.698 | 2 | 32 | 247 |
GO:0050998 | nitric-oxide synthase binding | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 16 |
GO:0014911 | positive regulation of smooth muscle cell migration | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 16 |
GO:0001894 | tissue homeostasis | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 1 | 17 |
GO:0022624 | proteasome accessory complex | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 8 | 17 |
GO:0006281 | DNA repair | 1.08e-02 | 1.00e+00 | 3.618 | 2 | 18 | 261 |
GO:0035861 | site of double-strand break | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 1 | 18 |
GO:0015078 | hydrogen ion transmembrane transporter activity | 1.18e-02 | 1.00e+00 | 6.398 | 1 | 3 | 19 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.18e-02 | 1.00e+00 | 6.398 | 1 | 1 | 19 |
GO:0048863 | stem cell differentiation | 1.18e-02 | 1.00e+00 | 6.398 | 1 | 1 | 19 |
GO:0006298 | mismatch repair | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 3 | 20 |
GO:0030325 | adrenal gland development | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 1 | 21 |
GO:0043548 | phosphatidylinositol 3-kinase binding | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 2 | 21 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 1 | 21 |
GO:0032201 | telomere maintenance via semi-conservative replication | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 5 | 21 |
GO:0032967 | positive regulation of collagen biosynthetic process | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 1 | 21 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 4 | 21 |
GO:0005856 | cytoskeleton | 1.33e-02 | 1.00e+00 | 3.461 | 2 | 12 | 291 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 3 | 22 |
GO:0030863 | cortical cytoskeleton | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 4 | 22 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 4 | 23 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 3 | 23 |
GO:0043236 | laminin binding | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 1 | 23 |
GO:0006024 | glycosaminoglycan biosynthetic process | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 1 | 23 |
GO:0006513 | protein monoubiquitination | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 1 | 23 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 2 | 23 |
GO:0048705 | skeletal system morphogenesis | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 1 | 24 |
GO:0000722 | telomere maintenance via recombination | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 5 | 25 |
GO:0019901 | protein kinase binding | 1.57e-02 | 1.00e+00 | 3.338 | 2 | 21 | 317 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 2 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 3 | 26 |
GO:0048008 | platelet-derived growth factor receptor signaling pathway | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 2 | 27 |
GO:0043022 | ribosome binding | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 3 | 27 |
GO:0030177 | positive regulation of Wnt signaling pathway | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 3 | 27 |
GO:0031492 | nucleosomal DNA binding | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 4 | 27 |
GO:0045840 | positive regulation of mitosis | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 2 | 28 |
GO:0019894 | kinesin binding | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 28 |
GO:0019005 | SCF ubiquitin ligase complex | 1.80e-02 | 1.00e+00 | 5.788 | 1 | 1 | 29 |
GO:0006271 | DNA strand elongation involved in DNA replication | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 7 | 30 |
GO:0032956 | regulation of actin cytoskeleton organization | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 1 | 30 |
GO:0001895 | retina homeostasis | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 1 | 34 |
GO:0034332 | adherens junction organization | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 1 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.29e-02 | 1.00e+00 | 5.437 | 1 | 4 | 37 |
GO:0048839 | inner ear development | 2.29e-02 | 1.00e+00 | 5.437 | 1 | 2 | 37 |
GO:0006284 | base-excision repair | 2.29e-02 | 1.00e+00 | 5.437 | 1 | 3 | 37 |
GO:0000278 | mitotic cell cycle | 2.33e-02 | 1.00e+00 | 3.035 | 2 | 48 | 391 |
GO:0005902 | microvillus | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 2 | 38 |
GO:0070527 | platelet aggregation | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 2 | 38 |
GO:0042542 | response to hydrogen peroxide | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 1 | 39 |
GO:0022627 | cytosolic small ribosomal subunit | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 4 | 39 |
GO:0000781 | chromosome, telomeric region | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 3 | 39 |
GO:0004715 | non-membrane spanning protein tyrosine kinase activity | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 4 | 42 |
GO:0021762 | substantia nigra development | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 2 | 44 |
GO:0043066 | negative regulation of apoptotic process | 2.71e-02 | 1.00e+00 | 2.918 | 2 | 31 | 424 |
GO:0032526 | response to retinoic acid | 2.83e-02 | 1.00e+00 | 5.123 | 1 | 2 | 46 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 2.83e-02 | 1.00e+00 | 5.123 | 1 | 7 | 46 |
GO:0043406 | positive regulation of MAP kinase activity | 2.83e-02 | 1.00e+00 | 5.123 | 1 | 4 | 46 |
GO:0055085 | transmembrane transport | 2.84e-02 | 1.00e+00 | 2.881 | 2 | 10 | 435 |
GO:0030670 | phagocytic vesicle membrane | 2.90e-02 | 1.00e+00 | 5.092 | 1 | 3 | 47 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 3.02e-02 | 1.00e+00 | 5.031 | 1 | 4 | 49 |
GO:0003684 | damaged DNA binding | 3.02e-02 | 1.00e+00 | 5.031 | 1 | 7 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 17 | 50 |
GO:0060326 | cell chemotaxis | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 2 | 50 |
GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling | 3.14e-02 | 1.00e+00 | 4.974 | 1 | 1 | 51 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 5 | 53 |
GO:0045216 | cell-cell junction organization | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 2 | 54 |
GO:0044267 | cellular protein metabolic process | 3.33e-02 | 1.00e+00 | 2.757 | 2 | 29 | 474 |
GO:0000724 | double-strand break repair via homologous recombination | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 3 | 55 |
GO:0000723 | telomere maintenance | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 6 | 56 |
GO:0012505 | endomembrane system | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 2 | 56 |
GO:0000502 | proteasome complex | 3.56e-02 | 1.00e+00 | 4.788 | 1 | 17 | 58 |
GO:0060337 | type I interferon signaling pathway | 3.56e-02 | 1.00e+00 | 4.788 | 1 | 2 | 58 |
GO:0019903 | protein phosphatase binding | 3.80e-02 | 1.00e+00 | 4.692 | 1 | 4 | 62 |
GO:0006302 | double-strand break repair | 3.80e-02 | 1.00e+00 | 4.692 | 1 | 4 | 62 |
GO:0043202 | lysosomal lumen | 3.86e-02 | 1.00e+00 | 4.669 | 1 | 1 | 63 |
GO:0042060 | wound healing | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 2 | 64 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 19 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 22 | 65 |
GO:0009636 | response to toxic substance | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 3 | 65 |
GO:0006289 | nucleotide-excision repair | 4.17e-02 | 1.00e+00 | 4.559 | 1 | 11 | 68 |
GO:0034329 | cell junction assembly | 4.17e-02 | 1.00e+00 | 4.559 | 1 | 1 | 68 |
GO:0003697 | single-stranded DNA binding | 4.17e-02 | 1.00e+00 | 4.559 | 1 | 5 | 68 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.29e-02 | 1.00e+00 | 4.517 | 1 | 22 | 70 |
GO:0032355 | response to estradiol | 4.35e-02 | 1.00e+00 | 4.496 | 1 | 5 | 71 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 4.41e-02 | 1.00e+00 | 4.476 | 1 | 20 | 72 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 4.53e-02 | 1.00e+00 | 4.437 | 1 | 6 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.53e-02 | 1.00e+00 | 4.437 | 1 | 22 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 4.59e-02 | 1.00e+00 | 4.417 | 1 | 2 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 4.59e-02 | 1.00e+00 | 4.417 | 1 | 20 | 75 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 4.82e-02 | 1.00e+00 | 4.342 | 1 | 23 | 79 |
GO:0001726 | ruffle | 4.88e-02 | 1.00e+00 | 4.324 | 1 | 4 | 80 |
GO:0019083 | viral transcription | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 10 | 81 |
GO:0045087 | innate immune response | 5.06e-02 | 1.00e+00 | 2.427 | 2 | 24 | 596 |
GO:0047485 | protein N-terminus binding | 5.24e-02 | 1.00e+00 | 4.220 | 1 | 5 | 86 |
GO:0006415 | translational termination | 5.30e-02 | 1.00e+00 | 4.203 | 1 | 10 | 87 |
GO:0016605 | PML body | 5.36e-02 | 1.00e+00 | 4.187 | 1 | 3 | 88 |
GO:0042470 | melanosome | 5.54e-02 | 1.00e+00 | 4.138 | 1 | 9 | 91 |
GO:0006928 | cellular component movement | 5.54e-02 | 1.00e+00 | 4.138 | 1 | 7 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 5.54e-02 | 1.00e+00 | 4.138 | 1 | 8 | 91 |
GO:0071456 | cellular response to hypoxia | 5.60e-02 | 1.00e+00 | 4.123 | 1 | 6 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 5.60e-02 | 1.00e+00 | 4.123 | 1 | 21 | 92 |
GO:0006414 | translational elongation | 5.66e-02 | 1.00e+00 | 4.107 | 1 | 13 | 93 |
GO:0010467 | gene expression | 6.23e-02 | 1.00e+00 | 2.260 | 2 | 59 | 669 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 6.31e-02 | 1.00e+00 | 3.946 | 1 | 10 | 104 |
GO:0014069 | postsynaptic density | 6.37e-02 | 1.00e+00 | 3.932 | 1 | 3 | 105 |
GO:0016023 | cytoplasmic membrane-bounded vesicle | 6.37e-02 | 1.00e+00 | 3.932 | 1 | 5 | 105 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 6.43e-02 | 1.00e+00 | 3.918 | 1 | 2 | 106 |
GO:0072562 | blood microparticle | 6.72e-02 | 1.00e+00 | 3.852 | 1 | 3 | 111 |
GO:0030529 | ribonucleoprotein complex | 6.78e-02 | 1.00e+00 | 3.839 | 1 | 8 | 112 |
GO:0048015 | phosphatidylinositol-mediated signaling | 6.89e-02 | 1.00e+00 | 3.813 | 1 | 7 | 114 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 6.89e-02 | 1.00e+00 | 3.813 | 1 | 11 | 114 |
GO:0019058 | viral life cycle | 6.95e-02 | 1.00e+00 | 3.801 | 1 | 13 | 115 |
GO:0000209 | protein polyubiquitination | 7.01e-02 | 1.00e+00 | 3.788 | 1 | 20 | 116 |
GO:0006325 | chromatin organization | 7.13e-02 | 1.00e+00 | 3.764 | 1 | 5 | 118 |
GO:0007219 | Notch signaling pathway | 7.25e-02 | 1.00e+00 | 3.739 | 1 | 5 | 120 |
GO:0006260 | DNA replication | 7.30e-02 | 1.00e+00 | 3.727 | 1 | 9 | 121 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7.60e-02 | 1.00e+00 | 3.669 | 1 | 5 | 126 |
GO:0030335 | positive regulation of cell migration | 7.65e-02 | 1.00e+00 | 3.657 | 1 | 7 | 127 |
GO:0016477 | cell migration | 7.71e-02 | 1.00e+00 | 3.646 | 1 | 5 | 128 |
GO:0000790 | nuclear chromatin | 7.77e-02 | 1.00e+00 | 3.635 | 1 | 9 | 129 |
GO:0006413 | translational initiation | 7.89e-02 | 1.00e+00 | 3.613 | 1 | 17 | 131 |
GO:0003735 | structural constituent of ribosome | 8.23e-02 | 1.00e+00 | 3.548 | 1 | 10 | 137 |
GO:0006457 | protein folding | 8.58e-02 | 1.00e+00 | 3.486 | 1 | 7 | 143 |
GO:0061024 | membrane organization | 8.69e-02 | 1.00e+00 | 3.466 | 1 | 7 | 145 |
GO:0042981 | regulation of apoptotic process | 8.98e-02 | 1.00e+00 | 3.417 | 1 | 24 | 150 |
GO:0010008 | endosome membrane | 9.04e-02 | 1.00e+00 | 3.408 | 1 | 7 | 151 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 9.33e-02 | 1.00e+00 | 3.361 | 1 | 9 | 156 |
GO:0046777 | protein autophosphorylation | 9.44e-02 | 1.00e+00 | 3.342 | 1 | 7 | 158 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 9.84e-02 | 1.00e+00 | 3.280 | 1 | 7 | 165 |
GO:0030424 | axon | 9.90e-02 | 1.00e+00 | 3.271 | 1 | 4 | 166 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 1.00e-01 | 1.00e+00 | 3.254 | 1 | 12 | 168 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.02e-01 | 1.00e+00 | 3.228 | 1 | 20 | 171 |
GO:0032403 | protein complex binding | 1.09e-01 | 1.00e+00 | 3.130 | 1 | 10 | 183 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.12e-01 | 1.00e+00 | 3.084 | 1 | 12 | 189 |
GO:0016021 | integral component of membrane | 1.15e-01 | 1.00e+00 | 1.278 | 3 | 27 | 1982 |
GO:0016324 | apical plasma membrane | 1.18e-01 | 1.00e+00 | 3.010 | 1 | 5 | 199 |
GO:0001701 | in utero embryonic development | 1.19e-01 | 1.00e+00 | 2.995 | 1 | 8 | 201 |
GO:0005634 | nucleus | 1.20e-01 | 1.00e+00 | 0.814 | 5 | 136 | 4559 |
GO:0019221 | cytokine-mediated signaling pathway | 1.30e-01 | 1.00e+00 | 2.858 | 1 | 9 | 221 |
GO:0006412 | translation | 1.35e-01 | 1.00e+00 | 2.801 | 1 | 20 | 230 |
GO:0004842 | ubiquitin-protein transferase activity | 1.48e-01 | 1.00e+00 | 2.652 | 1 | 6 | 255 |
GO:0005102 | receptor binding | 1.51e-01 | 1.00e+00 | 2.624 | 1 | 6 | 260 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 1.56e-01 | 1.00e+00 | 2.575 | 1 | 15 | 269 |
GO:0019899 | enzyme binding | 1.60e-01 | 1.00e+00 | 2.532 | 1 | 12 | 277 |
GO:0007186 | G-protein coupled receptor signaling pathway | 1.67e-01 | 1.00e+00 | 2.471 | 1 | 7 | 289 |
GO:0043234 | protein complex | 1.70e-01 | 1.00e+00 | 2.442 | 1 | 18 | 295 |
GO:0016567 | protein ubiquitination | 1.70e-01 | 1.00e+00 | 2.442 | 1 | 5 | 295 |
GO:0035556 | intracellular signal transduction | 1.74e-01 | 1.00e+00 | 2.403 | 1 | 9 | 303 |
GO:0043231 | intracellular membrane-bounded organelle | 1.82e-01 | 1.00e+00 | 2.333 | 1 | 9 | 318 |
GO:0007411 | axon guidance | 1.82e-01 | 1.00e+00 | 2.329 | 1 | 13 | 319 |
GO:0005737 | cytoplasm | 1.87e-01 | 1.00e+00 | 0.767 | 4 | 110 | 3767 |
GO:0007155 | cell adhesion | 2.08e-01 | 1.00e+00 | 2.119 | 1 | 6 | 369 |
GO:0005886 | plasma membrane | 2.08e-01 | 1.00e+00 | 0.897 | 3 | 45 | 2582 |
GO:0008284 | positive regulation of cell proliferation | 2.15e-01 | 1.00e+00 | 2.069 | 1 | 8 | 382 |
GO:0009986 | cell surface | 2.25e-01 | 1.00e+00 | 1.995 | 1 | 11 | 402 |
GO:0007596 | blood coagulation | 2.51e-01 | 1.00e+00 | 1.816 | 1 | 18 | 455 |
GO:0006468 | protein phosphorylation | 2.53e-01 | 1.00e+00 | 1.801 | 1 | 18 | 460 |
GO:0006915 | apoptotic process | 2.98e-01 | 1.00e+00 | 1.530 | 1 | 33 | 555 |
GO:0007165 | signal transduction | 4.43e-01 | 1.00e+00 | 0.821 | 1 | 24 | 907 |
GO:0005615 | extracellular space | 4.61e-01 | 1.00e+00 | 0.744 | 1 | 17 | 957 |
GO:0008270 | zinc ion binding | 4.75e-01 | 1.00e+00 | 0.685 | 1 | 12 | 997 |
GO:0044822 | poly(A) RNA binding | 4.96e-01 | 1.00e+00 | 0.602 | 1 | 49 | 1056 |
GO:0044281 | small molecule metabolic process | 5.46e-01 | 1.00e+00 | 0.404 | 1 | 58 | 1211 |
GO:0005730 | nucleolus | 6.63e-01 | 1.00e+00 | -0.034 | 1 | 69 | 1641 |